B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Kml29

6 PubMed studies analyzed ยท Evidence Score: 19.3

Research Domains

Kml29 has been studied across 8 research domains including ๐Ÿ’Š Pain, ๐Ÿ”ฌ Inflammation, ๐Ÿง  Neuroprotection, โค๏ธ Cardiovascular, ๐Ÿฆ  Gut & Microbiome. The primary research focus is ๐Ÿ’Š Pain with 50% of studies addressing this area.

Loading evidence profile...

This evidence profile for Kml29 is generated deterministically from 6 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.